PLSE
Price
$7.82
Change
-$0.23 (-2.86%)
Updated
May 3, 6:59 PM EST
One day until earnings call
VCYT
Price
$20.35
Change
+$0.16 (+0.79%)
Updated
May 3, 6:59 PM EST
One day until earnings call
Ad is loading...

Analysis and predictions PLSE vs VCYT

Header iconPLSE vs VCYT Comparison
Open Charts PLSE vs VCYTBanner chart's image
Pulse Biosciences
Price$7.82
Change-$0.23 (-2.86%)
Volume$109.36K
CapitalizationN/A
Veracyte
Price$20.35
Change+$0.16 (+0.79%)
Volume$220.74K
CapitalizationN/A
View a ticker or compare two or three
PLSE vs VCYT Comparison Chart

Loading...

PLSEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PLSE vs. VCYT commentary
May 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSE is a Hold and VCYT is a Hold.

COMPARISON
Comparison
May 06, 2024
Stock price -- (PLSE: $7.82 vs. VCYT: $20.35)
Brand notoriety: PLSE and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PLSE: 101% vs. VCYT: 68%
Market capitalization -- PLSE: $481.01M vs. VCYT: $1.66B
PLSE [@Medical Specialties] is valued at $481.01M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSE’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • PLSE’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, PLSE is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSE’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 6 bullish TA indicator(s).

  • PLSE’s TA Score: 5 bullish, 4 bearish.
  • VCYT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than PLSE.

Price Growth

PLSE (@Medical Specialties) experienced а +8.76% price change this week, while VCYT (@Medical Specialties) price change was +5.39% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.22%. For the same industry, the average monthly price growth was -2.71%, and the average quarterly price growth was +13.71%.

Reported Earning Dates

PLSE is expected to report earnings on Aug 08, 2024.

VCYT is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (+2.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for PLSE with price predictions.
OPEN
A.I.dvisor published
a Summary for VCYT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than PLSE($481M). VCYT YTD gains are higher at: -26.027 vs. PLSE (-36.111). PLSE has higher annual earnings (EBITDA): -42.37M vs. VCYT (-49.41M). VCYT has more cash in the bank: 216M vs. PLSE (44.4M). PLSE has less debt than VCYT: PLSE (9.14M) vs VCYT (12.6M). VCYT has higher revenues than PLSE: VCYT (361M) vs PLSE (0).
PLSEVCYTPLSE / VCYT
Capitalization481M1.66B29%
EBITDA-42.37M-49.41M86%
Gain YTD-36.111-26.027139%
P/E RatioN/AN/A-
Revenue0361M-
Total Cash44.4M216M21%
Total Debt9.14M12.6M73%
FUNDAMENTALS RATINGS
PLSE vs VCYT: Fundamental Ratings
PLSE
VCYT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
5076
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (35) in the Biotechnology industry is in the same range as PLSE (62) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to PLSE’s over the last 12 months.

VCYT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLSE (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to PLSE’s over the last 12 months.

VCYT's SMR Rating (92) in the Biotechnology industry is in the same range as PLSE (99) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (50) in the Medical Specialties industry is in the same range as VCYT (76) in the Biotechnology industry. This means that PLSE’s stock grew similarly to VCYT’s over the last 12 months.

PLSE's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as VCYT (100) in the Biotechnology industry. This means that PLSE’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSEVCYT
RSI
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
PLSEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRMEX6.920.07
+1.02%
CRM All Cap Value Inv
RTSCX30.900.27
+0.88%
Russell Inv Tax-Managed US Mid&Sm Cap C
TIEWX13.860.11
+0.80%
Nuveen International Eq W
TRMNX18.380.14
+0.77%
T. Rowe Price Mid-Cap Index
CSHAX9.510.04
+0.42%
MainStay Cushing® MLP Premier A

PLSE and

Correlation & Price change

A.I.dvisor tells us that PLSE and IRTC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSE and IRTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-2.86%
IRTC - PLSE
32%
Poorly correlated
-7.40%
VCYT - PLSE
31%
Poorly correlated
+0.79%
BFLY - PLSE
31%
Poorly correlated
+2.28%
RXST - PLSE
30%
Poorly correlated
+3.44%
KIDS - PLSE
29%
Poorly correlated
+3.21%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+0.79%
NTLA - VCYT
69%
Closely correlated
+1.42%
VCEL - VCYT
60%
Loosely correlated
-0.10%
AXON - VCYT
58%
Loosely correlated
+0.57%
TWST - VCYT
57%
Loosely correlated
+28.74%
DNA - VCYT
57%
Loosely correlated
+10.90%
More